Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma
Clinical trial NCT06831136 · RECRUITING
Trial details
- NCT number
- NCT06831136
- Sponsor
- The University of Texas Health Science Center, Houston
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-26
- Primary completion
- 2028-01-20
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.